Invention Grant
- Patent Title: WT1 HLA class II-binding peptides and compositions and methods comprising same
-
Application No.: US16270444Application Date: 2019-02-07
-
Publication No.: US11548924B2Publication Date: 2023-01-10
- Inventor: David Scheinberg , Javier Pinilla-Ibarz , Rena May
- Applicant: Memorial Sloan Kettering Cancer Center
- Applicant Address: US NY New York
- Assignee: Memorial Sloan Kettering Cancer Center
- Current Assignee: Memorial Sloan Kettering Cancer Center
- Current Assignee Address: US NY New York
- Agency: Pearl Cohen Zedek Latzer Baratz LLP
- Agent Mark S. Cohen
- Main IPC: C07K14/47
- IPC: C07K14/47 ; A61K39/00 ; A61K38/00
Abstract:
This invention provides WT1 peptides and methods of treating, reducing the incidence of, and inducing immune responses against a WT1-expressing cancer, comprising same.
Public/Granted literature
- US20190322713A1 WT1 HLA CLASS II-BINDING PEPTIDES AND COMPOSITIONS AND METHODS COMPRISING SAME Public/Granted day:2019-10-24
Information query
